First-pass extracted concept

endocannabinoid system

Candidate: concept label3 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

ECS

Evidence Snippets

Its ability to interact with the endocannabinoid system to reduce nociception (pain perception) and inflammation makes it particularly suitable for the complex symptom burden of patients with head and neck cancer.

Evidence 1Source 1DOI PubMedprovenance

The endocannabinoids system (ECS) has garnered considerable interest as a potential therapeutic target in various carcinomas and cancer-related conditions alongside neurodegenerative diseases.

Evidence 2Source 2DOI PubMedprovenance

A growing body of work indicates that the endocannabinoid (eCB) system is an integral regulator of the stress response.

Evidence 3Source 3DOI PubMedprovenance

Supporting Sources

Source 1review2026MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2review2018MedicinesDOI PubMed

1 evidence snippet 0 linked claims

Source 3review2015NeuropsychopharmacologyDOI PubMed

1 evidence snippet 2 linked claims Claim 1 Claim 2

Linked Claims

Claim 1mechanistic rationalesupports2026Source 1DOI PubMed

The review states that medical cannabis interacts with the endocannabinoid system to reduce nociception and inflammation.

Claim 2overall modelsupports2015Source 3DOI PubMed

Endocannabinoid signaling is an important brain regulatory system that largely buffers against many effects of stress, and dynamic changes in this system contribute to different aspects of the stress response.

Claim 3translational relevancesupports2015Source 3DOI PubMed

Human translational studies indicate that endocannabinoid signaling regulates many of the same stress-related domains and that impairments in this system may be involved in vulnerability to depression and posttraumatic stress disorder.